Diabetes mellitus T1DM (Type1)

Immunology of type 1 diabetes.
[15955793] QJM 98(8): 547-56 (2005)

Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus.
[17656810] Neth J Med 65(7): 235-47 (2007)

Autoantibodies against multiple tissues in type 1 diabetes.
[17656808] Neth J Med 65(7): 225-6 (2007)

Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
[15191683] Health Technol Assess 8(22): iii-xi, 1-183 (2004)

Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell.
[19128357] Clin Exp Immunol 155(2): 125-7 (2009)

Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?
[20144352] J Diabetes Sci Technol 3(2): 215-8 (2009)

Treatment of patients who have type 1 diabetes mellitus: physiological misconceptions and infusion pump therapy.
[12198989] J Am Dent Assoc 133(8): 1088-92; quiz 1095 (2002)

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
[9836516] Diabetes 47(12): 1857-66 (1998)

Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening.
[16403820] J Clin Endocrinol Metab 91(4): 1210-7 (2006)

Type 1 diabetes: pathogenesis and prevention.
[16847277] CMAJ 175(2): 165-70 (2006)

Insulin-dependent (type I) diabetes mellitus.
[1933705] CMAJ 145(10): 1227-37 (1991)

What causes type 1 diabetes? Lessons from animal models.
[21615797] APMIS Suppl 119 132(-): 1-19 (2011)

Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.
[19248096] Arthritis Rheum 60(3): 653-60 (2009)

The role of perforin and granzymes in diabetes.
[19927156] Cell Death Differ 17(4): 577-85 (2010)

Clinical applications of diabetes antibody testing.
[19875480] J Clin Endocrinol Metab 95(1): 25-33 (2010)

Autoimmune gastritis in type 1 diabetes: a clinically oriented review.
[18029461] J Clin Endocrinol Metab 93(2): 363-71 (2008)

Hypoglycemia in type 1 diabetes mellitus.
[20723825] Endocrinol Metab Clin North Am 39(3): 641-54 (2010)

Use of nonobese diabetic mice to understand human type 1 diabetes.
[20723819] Endocrinol Metab Clin North Am 39(3): 541-61 (2010)

Efforts to prevent and halt autoimmune beta cell destruction.
[20723818] Endocrinol Metab Clin North Am 39(3): 527-39 (2010)

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
[17613449] Endocr Pract 13 Suppl 1(-): 1-68 (2007)

Enteroviral pathogenesis of type 1 diabetes.
[20807476] Discov Med 10(51): 151-60 (2010)

Autoantigen based vaccines for type 1 diabetes.
[21524383] Discov Med 11(59): 293-301 (2011)

Innate immunity in type 1 diabetes.
[21712017] Discov Med 11(61): 513-20 (2011)

Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.
[11927613] J Clin Invest 109(7): 869-70 (2002)

Update on worldwide efforts to prevent type 1 diabetes.
[19120293] Ann N Y Acad Sci 1150(-): 190-6 (2008)

Type 1 diabetes in children - emergency management.
[20485715] Aust Fam Physician 39(5): 290-3 (2010)

Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.
[20009114] Neth J Med 67(11): 376-87 (2009)

Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?
[18082388] Curr Opin Immunol 20(1): 105-10 (2008)

The immunotherapeutic potential of dendritic cells in type 1 diabetes.
[20491789] Clin Exp Immunol 161(2): 197-207 (2010)

On the mechanisms of the protective effect of infections on type 1 diabetes.
[15559363] Clin Dev Immunol 11(3-4): 191-4 (2004)

NK cells and type 1 diabetes.
[17162353] Clin Dev Immunol 13(2-4): 101-7 (2006)

Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
[15793184] Diabetes Care 28(4): 850-5 (2005)

Beta-cell protection and therapy for latent autoimmune diabetes in adults.
[19875559] Diabetes Care 32 Suppl 2(-): S246-52 (2009)

New developments in the treatment of type 1 diabetes in children.
[17954479] Arch Dis Child 92(11): 1015-9 (2007)

Psychosocial problems in adolescents with type 1 diabetes mellitus.
[19700362] Diabetes Metab 35(5): 339-50 (2009)

Lipid disorders in type 1 diabetes.
[19733492] Diabetes Metab 35(5): 353-60 (2009)

HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.
[19918326] Int J Clin Exp Pathol 3(1): 24-38 (2009)

Diabetes education for children with type 1 diabetes mellitus and their families.
[18620470] Evid Rep Technol Assess (Full Rep) -(166): 1-144 (2008)

The role of immunomodulation therapy in autoimmune diabetes.
[20144363] J Diabetes Sci Technol 3(2): 320-30 (2009)

The role of innate immune pathways in type 1 diabetes pathogenesis.
[20125005] Curr Opin Endocrinol Diabetes Obes 17(2): 126-30 (2010)

Change you can B(cell)eive in: recent progress confirms a critical role for B cells in type 1 diabetes.
[19502979] Curr Opin Endocrinol Diabetes Obes 16(4): 293-8 (2009)

Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.
[17491686] Rev Diabet Stud 2(3): 116-20 (2005)

The role of the CXCL10/CXCR3 system in type 1 diabetes.
[19806237] Rev Diabet Stud 6(2): 81-4 (2009)

Histopathology of type 1 diabetes: old paradigms and new insights.
[19806238] Rev Diabet Stud 6(2): 85-96 (2009)

Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.
[20039010] Rev Diabet Stud 6(3): 211-22 (2009)

Insulitis in human type 1 diabetes: The quest for an elusive lesion.
[21606672] Islets 3(4): 131-8 (2011)

Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function.
[21966328] Open Med Chem J 5(Suppl 2): 78-81 (2011)

Noninsulin pharmacological management of type 1 diabetes mellitus.
[21847455] Indian J Endocrinol Metab 15(Suppl 1): S5-S11 (2011)

C-peptide in the natural history of type 1 diabetes.
[19267337] Diabetes Metab Res Rev 25(4): 325-8 (2009)

The pancreas in human type 1 diabetes.
[20495921] Semin Immunopathol 33(1): 29-43 (2011)

An update on the use of NOD mice to study autoimmune (Type 1) diabetes.
[20979558] Expert Rev Clin Immunol 6(6): 939-55 (2010)

Combination therapies for type 1 diabetes: why not now?
[20635894] Immunotherapy 2(3): 289-91 (2010)

APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes.
[19036642] Clin Immunol 130(3): 272-9 (2009)

Teplizumab therapy for type 1 diabetes.
[20095914] Expert Opin Biol Ther 10(3): 459-65 (2010)

Attacking the source: anti-PDX-1 responses in type 1 diabetes.
[20038945] Lab Invest 90(1): 6-8 (2010)

Prediction and pathogenesis in type 1 diabetes.
[20412757] Immunity 32(4): 468-78 (2010)

Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis.
[20412758] Immunity 32(4): 479-87 (2010)

Immunotherapy of type 1 diabetes: where are we and where should we be going?
[20412759] Immunity 32(4): 488-99 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus T1DM (Type1).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus T1DM (Type1).php on line 92